EDIMER PHARMACEUTICALS

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers.

#SimilarOrganizations #People #Financial #Website #More

EDIMER PHARMACEUTICALS

Social Links:

Twitter

Industry:

Biotechnology Health Care Life Science

Founded:

2009-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.edimerpharma.com

Total Employee:

Status:

Active

Contact:

(866)334-4240

Email Addresses:

[email protected]

Total Funding:

40 M USD

Technology used in webpage:

SPF Amazon Amazon Ohio Region NameBright

Similar Organizations

edison-pharmaceuticals-logo

Current Advisors List

david-mott_image

David Mott Board of Directors @ Edimer Pharmaceuticals
Board_member

philip-reilly_image

Philip Reilly Board Member @ Edimer Pharmaceuticals
Board_member
2009-01-01

cary-pfeffer_image

Cary Pfeffer Board Member @ Edimer Pharmaceuticals
Board_member

wendy-dixon_image

Wendy Dixon Member of the Board of Directors @ Edimer Pharmaceuticals
Board_member

Founder

neil-kirby_image

Neil Kirby

Investors List

third-rock-ventures_image

Official Site Inspections

http://www.edimerpharma.com

Host Informations
Whois Informations

Loading ...